Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
NCT05738681
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Drug Induced Liver Injury
Hepatitis
Interventions
DRUG:
N acetyl cysteine
Sponsor
Mahidol University